Ledger.Open graph →
SEC Form D · Amendment · filed November 15, 2013

Aerpio Therapeutics, Inc

Offering
$31.0M
Sold
$27.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CINCINNATI, OH
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Lauren H. Silverman · Cincinnati, OHDirectorRichard S. Ruffer · New York, NYDirectorWilliam Daly · Cincinnati, OHExecAlan Fishman · Cincinnati, OHExecHal J. Strong · San Francisco, CADirectorJohn Anderson · New York, NYDirectorBlaine Bailey · Vancouver, British Columbia, CanadaExec · DirectorMarla Mahloch · Saint Peteresburg, FLDirectorGary J. Michel · San Francisco, CAExecRobert H. Shalwitz · Cincinnati, OHExecGary Retelny · Rockville, MDDirectorJeffery M. Lamberson · post falls, IDDirectorSteven Friedman · Rockville, MDExec · DirectorGeoffrey Miller · San Francisco, CADirectorBenjamin J. Brigeman · San Francisco, CADirectorAllen Heery · Rockville, MDDirectorJohn G. Blake · Dublin, IrelandDirectorDerval G. Murray · Dublin, IrelandDirectorRichard Crawshaw · Wilmington, DEDirectorClive Harris · Wilmington, DEExecDerval G. Murray · Dublin, IrelandDirectorDavid S. Shapiro · Arlington, VAExecKimberly A. Ramsey · Newberry, FLExecSuha R. Jhaveri · Newberry, FLExecNicholas Romig · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗